Background {#Sec1}
==========

Today, percutaneous dilatational tracheostomy (PDT) has become one of the most commonly used interventions in ICU medicine \[[@CR1]--[@CR4]\]. Different techniques have been developed, but guidance by video bronchoscope has been suggested to be clinically reasonable for direct visualization of tracheal puncture \[[@CR5]--[@CR10]\]. In particular, such guidance is anticipated to find the optimal puncture side, to avoid infringing of the tracheal cartilage and to secure placement of the cannula in the optimal position \[[@CR11]\]. Thus, guidance of bronchoscopy during PDT has widely been accepted to reduce complication rates, most importantly the injury of the tracheal posterior wall \[[@CR12]--[@CR16]\]. Therefore, in Germany, 97.7% of all ICUs use bronchoscopes to guide tracheostomy \[[@CR17]\]. However, one of the major disadvantages of bronchoscopic guidance is the partial occlusion of the endotracheal tube (ET), leading to impaired alveolar ventilation. Surprisingly, few studies have evaluated the effect of bronchoscopy during PDT on gas exchange, in particular CO~2~ retention. Here, one early study has reported a mean increase in PaCO~2~ of 24 mmHg \[[@CR18], [@CR19]\]. In addition, a substantial increase in PaCO~2~ has also been established during flexible bronchoscopy in stable patients using sedation practices \[[@CR20]\].

However, PCO~2~ is frequently not monitored during PDT in clinically routine. Even though high levels of hypercapnia are suggested to be generally tolerated by patients, negative effects of hypercapnia on organ function, most importantly regulation of cerebral blood flow \[[@CR20]\], worsening of right heart function \[[@CR21], [@CR22]\] and catecholamine excess in severe hypercapnia \[[@CR23], [@CR24]\] have also been reported. In particular, the impact of dynamic alterations with rapidly changing PCO~2~ and pH values on organ function in ICU patients with already existing organ dysfunction has yet not been fully elucidated. In this regard, there is no guideline-based recommendation regarding how to therapeutically respond to worsening alveolar ventilation resulting from the intervention. In particular, it also remains unclear whether actions such as choosing a larger ET size or increasing tidal volumes during the procedure are capable of attenuating or even avoiding the intervention-related increase in PCO~2~. This area has never been systematically investigated.

For these reasons, the present study was primarily aimed at assessing, firstly, the impact of bronchoscopy during PDT on periprocedural hypercapnic acidosis and, secondly, the impact of changing the ventilator settings in dependence of the tube size. Thereby, it was hypothesized that, first, there will be a significant increase in PaCO~2~ during PDT resulting in respiratory acidosis, and, secondly, that this increase could be attenuated by increasing the tidal volume (V~t~) during the procedure and by choosing larger ET sizes. Secondarily, it was also hypothesized that the increase in PaCO~2~ during PDT is a dynamic process, which could be further displayed by transcutaneous PCO2 monitoring (PtcCO~2~). If so, this technique would be capable of helping physicians to more safely perform PDT.

Methods {#Sec2}
=======

The study was approved by the Ethics Committee of the Witten/Herdecke University (research ethics board number 101/2015 -- August 2015) and registered at the German Clinical Trial Register and the WHO trial register (DRKS00011004).

Study design {#Sec3}
------------

Patients with acute respiratory failure requiring invasive mechanical ventilation following intubation and planned for PDT were included into the study. Patients were eligible if informed consent could be obtained from the caregivers or legal guardians, respectively, in advance and if ventilator settings revealed a positive end expiratory pressure (PEEP)-level of ≤15 cmH~2~O and a V~t~ of 6 ml/kg predicted body weight (PBW), resulting in an arterial pH \> 7.20. ET sizes had been determined clinically on individual requirements prior to the study, and these sizes were not subject to alteration during the study.

Prior to the intervention, all patients were ventilated with a fraction of inspired oxygen (FiO~2~) of 1.0 and then sedated to a Richmond Agitation Sedation Scale (RASS) of − 5, with muscle relaxants then being administered (1 mg/kg body weight rocuronium bromide). PtcCO~2~ was continuously monitored using a SenTec Digital Monitor with a sampling rate of one measurement per minute (SenTec Digital Monitoring System; SenTec AG; Ref.: 005856, MPB-Software: V05.00.15 and SMB-Software: V07.00.6; SenTec AG, Therwil, Switzerland) as described previously \[[@CR21], [@CR22]\]. Equilibrium measurements were established prior to intervention. A sensor was placed on the forehead of the patient at least 60 min prior to the start of the study.

Arterial blood gas analysis was performed at the beginning of the intervention (start), at the end (end) and at 30 min after the intervention (end+ 30 min). The beginning of the intervention was defined as the time when placing the bronchoscope into the endotracheal tube. Accordingly, the end of the intervention was defined as the time when the bronchoscope was removed after having successfully placed the tracheal cannula. A typical example is provided in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Typical example of recording transcutaneous PCO~2~ during dilatational tracheostomy (endotracheal tube size 7.5 mm ID). Arterial blood gas analysis was measured at the start, the end and the end+ 30 min, respectively

Two groups of patients were consecutively investigated. For both groups, pressure-controlled ventilation (Servo-I, Maquet Cardiopulmonary, Rastatt, Germany) was used throughout the entire study. Initially, ventilation was aimed at achieving a V~t~ of 6 ml/kg PBW as was done also clinically in these patients prior to the intervention (low V~t~ group). Then, a V~t~ of 12 ml/kg PBW was chosen in subsequent patients (high V~t~ group). Investigators were not blinded for the V~t~ groups. Adjustment to 12 ml/kg PBW for the purpose of the study was initiated just before the bronchoscope was inserted through the endotracheal tube. V~t~ was then reduced to 6 ml/kg PBW immediately after the bronchoscope was removed from the endotracheal tube. No further changes in ventilator settings were dictated by the study protocol. Respiratory rate, PEEP and inspiration-to-expiration ratio were maintained at a level set by the clinician prior to the procedure.

Technically, PDT was guided by video bronchoscopy (Olympus BF-Q180, maximal diameter 5.5 mm) and performed using the technique described by Ciaglia et al. (Ciaglia Blue Rhino® G2, COOK medical, Bloomington, USA) \[[@CR25]\]. Between the start and end of the procedure, the bronchoscope was not intermittently removed due to safety reasons (possible ET displacement) and also in order to keep the duration of the procedure at a minimum. Tracheostomy was positioned in the midline of the trachea below the second to fourth tracheal ring as described previously \[[@CR26]\]. For that purpose, a tracheal cannula with an internal diameter (ID) of 8.0 mm was preferentially chosen. All interventions were performed by an experienced intensivist or by a trainee under the direct supervision of the experienced intensivist.

Statistical analysis {#Sec4}
--------------------

For statistical analysis, the Kruskal--Wallis one-way analysis of variance was used to compare three parameters, and the Mann-Whitney test was employed to compare 2 parameters. PaCO~2~ was compared to PtcCO~2~ at three different time points: start of the intervention, end of the intervention and 30 min after the end of the procedure. For this purpose, both correlation (spearman's correlation) and Bland-Altman analyses were performed using GraphPad prism version 7.

Results {#Sec5}
=======

Sixty-three patients were included in the study. Patient characteristics and baseline physiological data are provided in Table [1](#Tab1){ref-type="table"}. In eight patients, tracheal rings were fractured without significant clinical impact, even after decannulation. The intervention was not interrupted or discontinued in any case.Table 1Patient's characteristics, ventilator settings and blood gas analysis prior to tracheostomy (PBW -- predicted body weight)Main characteristics6 ml/kg PBW group12 ml/kg PBW groupPatient Number*N* = 29*N* = 34Age \[years\]57.4 ± 14.559.5 ± 12.8Tracheostomy \[day\]16.8 ± 8.316.3 ± 8.9SAPS II36.7 ± 10.636.5 ± 10.0FiO~2~0.42 ± 0.100.41 ± 11.5P/F ratio \[mmHg\]241.1 ± 196.6211.6 ± 66.7V~t~ \[ml\]461.8 ± 102.3462.9 ± 108.7Breathing frequency \[/min\]20.8 ± 3.420.2 ± 3.0Driving Pressure \[cmH~2~O\]14.6 ± 4.812.7 ± 3.6PIP \[cmH~2~O\]26.1 ± 5.824.3 ± 6.3PEEP \[cmH~2~O\]11.3 ± 2.911.6 ± 3.1pH7.37 ± 0.077.36 ± 0.06PaO~2~ \[mmHg\]81.8 ± 14.777.6 ± 17.4PaCO~2~ \[mmHg\]50.9 ± 12.957.0 ± 15.2Data are presented as mean with standard deviation

Low V~t~ group {#Sec6}
--------------

Overall, 29 patients were investigated in the low V~t~ group: 10 patients with an ET of 7.5 mm ID, 11 patients with an ET of 8.0 mm ID, and 8 patients with an ET of 8.5 mm ID, respectively. The corresponding intervention time was 12 ± 3, 11 ± 3 and 9 ± 3 min, respectively. There was a statistically significant and substantial increase in PaCO~2~ during the intervention (start to end), whereas PaCO~2~ substantially decreased following the intervention (end + 30 min) (Fig. [2](#Fig2){ref-type="fig"}). Correspondingly, pH significantly and substantially decreased and subsequently increased, respectively (Additional files [1](#MOESM1){ref-type="media"} and [4](#MOESM4){ref-type="media"}).Fig. 2PaCO~2~ during dilatational tracheostomy. Tidal volume was set to 6 ml/kg PBW for the entire period. \**p* ≤ 0.05, \*\**p* ≤ 0.01 and \*\*\**p* ≤ 0.001. (ET - endotracheal tube, I.D. - internal diameter). Data were analyzed according to the diameter of the tube (**a**: 7.5mm, **b**: 8.0mm and **c**: 8.5mm)

High VT group {#Sec7}
-------------

Overall, 34 patients were investigated in the high V~t~ group: 11 patients with an ET of 7.5 mm ID, 13 patients with an ET of 8.0 mm ID and 10 patients with an ET of 8.5 mm ID, respectively. The corresponding intervention time was 10 ± 3, 10 ± 3 and 9 ± 3 min, respectively. There was a substantial increase in PaCO~2~ during the intervention (start to end), whereas PaCO~2~ substantially reduced following the intervention (end + 30 min) (Fig. [2](#Fig2){ref-type="fig"}). Correspondingly, pH markedly decreased and subsequently increased, respectively (Additional files [1](#MOESM1){ref-type="media"} and [4](#MOESM4){ref-type="media"}). However, changes in PaCO~2~ and pH were attenuated with larger tube sizes and even did not reach statistical significance when using an ET of 8.5 mm ID.

Comparison of low and high V~t~ groups {#Sec8}
--------------------------------------

The increase in PaCO~2~ and the reduction in pH, respectively, were comparable with regard to different V~t~ when using an ET of 7.5 mm ID (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}, Additional files [1](#MOESM1){ref-type="media"}, [2](#MOESM2){ref-type="media"}, [3](#MOESM3){ref-type="media"} and [4](#MOESM4){ref-type="media"}). When using an ET of 7.5 mm ID, the minute ventilation decreased during the intervention to a minimum, and this ventilation was unchanged when comparing low and high V~t~ (Fig. [5](#Fig5){ref-type="fig"}). In contrast, when using larger ET IDs, the minute ventilation during the intervention was higher when using high V~t~ compared to low V~t~. When comparing low and high V~t~, the difference in the increase in PaCO~2~ and the decrease in pH during the intervention, respectively, were more evident with higher ET IDs. Thus, respiratory acidosis occurring during the intervention could be at best attenuated when using an ET ID of 8.5 mm, while simultaneously using a V~t~ of 12 ml/kg PBW.Fig. 3Increase of PaCO~2~ during dilatational tracheostomy. Arterial blood gas analysis was performed at the beginning and end of the procedure. Patients were ventilated with tidal volumes (V~t~) of 6 or 12 ml/kg PBW during intervention. \**p* ≤ 0.05 and \*\**p* ≤ 0.01. (ET - endotracheal tube, I.D. - internal diameter). Data were analyzed according to the diameter of the tube (**a**: 7.5mm, **b**: 8.0mm and **c**: 8.5mm)Fig. 4Correlation of transcutaneous PCO~2~ (PtcCO~2~) and arterial PCO~2~ (PaCO~2~) (**a**). Corresponding Bland-Altman analysis are given in (**b**). (r - spearman's correlation; LoA - Limits of Agreement). Please note that the bias line for the Bland-Altman analysis is not visible due to the observation that the bias was close to zeroFig. 5Minute ventilation during dilatational tracheostomy. Tidal volume was set to 6 ml/kg PBW (**a**, **c** and **e**) or 12 ml/kg PBW (**b**, **d** and **f**) for the entire period. \**p* ≤ 0.05, \*\**p* ≤ 0.01 and \*\*\**p* ≤ 0.001. (ET - endotracheal tube, I.D. - internal diameter)

Comparison of PaCO~2~ and PtcCO~2~ {#Sec9}
----------------------------------

Hypercapnia immediately started to occur at the beginning of the intervention as assessed by PtcCO~2~ monitoring. A typical example of PtcCO~2~ monitoring during PDT is displayed in Fig. [1](#Fig1){ref-type="fig"}. PaCO~2~ and PtcCO~2~ were significantly correlated (*r* = 0.87, *p* \< 0.001, Fig. [4](#Fig4){ref-type="fig"}a). The corresponding Bland-Altman analysis is displayed in Fig. [4](#Fig4){ref-type="fig"}b (Bias 0.65 ± 9.4 mmHg within the limits of agreement from − 17.8 to 19.1 mmHg).

Discussion {#Sec10}
==========

The current study has demonstrated that there is a rapidly evolving respiratory acidosis during bronchoscopy-guided PDT. Thereby, the increase in PaCO~2~ is substantial and results from a reduced minute ventilation following bronchoscopy-related ET occlusion if pressure-controlled ventilation is used with established settings, aiming at lung protective ventilation. The present study has, furthermore, illustrated that an increase in V~t~ from 6 to 12 ml/kg PBW is capable of attenuating respiratory acidosis resulting from bronchoscopy-guided PDT. However, this effect was shown to be significantly dependent on ET size. Here, when using an ET of 7.5 mm ID, increasing V~t~ as described above did not result in a significant attenuation of respiratory acidosis, and this lack of attenuation is suggested to be related to the observation that the ET is sub-totally occluded by the bronchoscope when using an ET of 7.5 mm ID, thus preventing minute ventilation to be increased despite increasing inspiratory pressures aimed at achieving a V~t~ of 12 ml/kg PBW. This work also provides evidence for the impact of smaller bronchoscopes potentially improving alveolar ventilation compared to larger ones, but this area was not investigated in the present study.

As an alternative approach to ET, using a laryngeal mask is suggested to be associated with an attenuation of the increase in PCO~2~. However, there is an ongoing debate on whether laryngeal masks should be used for PDT. In this regard, a recent Cochrane analysis \[[@CR27]\] revealed a higher probability of a failing procedure and an uncertainty of serious adverse events when using laryngeal masks. Furthermore, at least in the ICU setting used for the current study changing the airway access is at risk for even severe complications, and this should be weighted against the benefit of a less severe increase in PCO~2~.

In contrast, when using larger ET IDs, minute ventilation was shown to be increased with higher V~t~. Accordingly, respiratory acidosis occurring during bronchoscopy-guided PDT could be most successfully attenuated when combing an ET of 8.5 mm ID with a V~t~ of 12 ml/kg PBW during the intervention. In the present study, however, only pressure-controlled ventilation was used. Theoretically, volume-controlled ventilation allowing for high inspiratory pressures is suggested to provide further advantages, at least if the airway is not sub-totally occluded when using considerably low ET sizes as discussed above. However, this is clearly dependent on how alarm settings are chosen, which in this study already reached 45 cmH~2~O. Therefore, best ventilator settings aimed at avoiding PDT-related respiratory acidosis need to be established in the future. Finally, the study has also shown that PtcCO~2~ monitoring is a reliable tool for displaying the dynamic change of alveolar ventilation during bronchoscopy-guided PDT in the ICU.

The present study has some important clinical implications. Firstly, vasodilatation as caused by hypercapnia and rapidly occurring respiratory acidosis can result in an increased cerebral pressure \[[@CR20]\], electrolyte disturbances and impairment of infection control \[[@CR28], [@CR29]\], whereas pulmonary vasoconstriction is prone to worsening of right and left heart function \[[@CR22], [@CR23]\]. Even though impairments of infection control are suggested to be of minor importance given the short intervention time, all other physiological changes related to rapidly occurring respiratory acidosis may be of particular importance for patients with predisposing conditions such as neurosurgical patients or those with multi organ failure. Thus, respiratory acidosis occurring during bronchoscopy-guided PDT as described in the present study may be harmful for ICU patients.

Secondly, clinicians should be aware that the increase of PCO~2~ during for bronchoscopy-guided PDT could be attenuated by the combination of an increased V~t~ (12 versus 6 ml/kg PBW) and a larger ET size (≥8 mm ID), but this statement is not true when only using a smaller ET size (\< 8 mm ID). Theoretically, changing the ET prior to the intervention could be advantageous when solely examining the results of the current findings, but this approach is suggested to be not generally recommended for clinical routine due to the general risk of changing a tube for severely ill patients. Importantly, an increase in the V~t~ was entirely restricted to the duration of the procedure; thus, lung protective ventilation is unlikely to be abandoned. In contrast, real alveolar ventilation is still reduced as evidenced by further increased PCO~2~ values. Therefore, restricting an increase in V~t~ for the duration of the intervention is highly unlikely to cause harm for the lungs but is suggested to be capable of minimizing the occurrence of hypercapnia when using larger ET sizes as described above.

Thirdly, PCO~2~ immediately starts to increase at the beginning of the intervention and also steadily continues to increase until the intervention has finished. Accordingly, pH values consistently decrease, resulting in severe respiratory acidosis. Therefore, there is evidence to suggest that the intervention time plays a fundamental role in the occurrence of respiratory acidosis resulting from bronchoscopy-guided PDT. The duration of the intervention in the current study was in a clinically acceptable range. However, an extended duration of the intervention is prone to substantially aggravate respiratory acidosis, particularly if increasing the V~t~ is unlikely to improve alveolar ventilation in case of using smaller ET sizes, as discussed above in detail. Therefore, the duration of the intervention must be kept at a minimum *or* the bronchoscope has to be removed intermittently to allow alveolar ventilation.

Finally, the current study also provides evidence that PtcCO~2~ monitoring is a reliable and helpful tool to assess the dynamic process of worsening hypercapnia. Importantly, the bias as calculated by Bland and Altman analysis ranged between − 0.5 and 1.8 mmHg, a result which is suggested to be clinically acceptable, particularly in view of previous findings in ICU medicine \[[@CR30], [@CR31]\]. Thereby, PtcCO~2~ monitoring clearly provides 2 important clinical advantages. First, the trend of PCO~2~ evolution is individually accessible. Second, this technique overcomes the disadvantage of spot measurements with delayed result presentation as valid for arterial blood gas analysis. Clinically, the assessment of the dynamics in hypercapnia development may help the investigator to decide to intermittently remove the bronchoscope during the procedure to guarantee maintenance of alveolar ventilation. This area, however, was not addressed in the present study and requires further investigation also considering higher complication rates related to ET displacements and longer intervention duration.

In addition, PtcCO~2~ monitoring is also suggested to be superior over end tidal PCO~2~ monitoring because ventilation-perfusion mismatching regularly occurring in ICU patients is suggested to distort PCO~2~ measurements when using end tidal monitoring \[[@CR32]--[@CR34]\]. However, there was a significant range of the limits of agreement between arterial and transcutaneous PCO~2~ measurements in the present study, a range which was even somewhat higher than previously reported in patients receiving mechanical ventilation \[[@CR32]--[@CR34]\]. This observation may be attributed to the special clinical scenario with high individual stress levels when performing the intervention and catecholamine treatment. This drawback, however, could be overcome by relating individual arterial and transcutaneous PCO~2~ measurements prior to the intervention. Furthermore, the PCO~2~ trend over time is suggested to be at least as important as the exact PCO~2~ measurement during intervention.

There are, however, some limitations of the present study. Firstly, patients were not randomized to receive 6 or 12 ml/kg PBW. However, it is suggested that this lack of randomization did not affect the results given the clear differences between the 2 ventilatory approaches, the fact that patients were not aware of the modality chosen and the tight-fitting baseline characteristics of both groups. Secondly, the number of patients in each group defined by specific levels of V~t~ and ET size was relatively small, and also not standardized, respectively. Here, the decision to select a specific ET size was taken in the emergency situation prior to the investigation, and changing ET tubes for standardisation was considered to be unethical.

Conclusion {#Sec11}
==========

In conclusion, the present study has demonstrated that hypercapnia and, consequently, profound respiratory acidosis following bronchoscopy-guided percutaneous dilatational tracheostomy evolves in a rapid and dynamic process. These changes were reportedly related to substantially reduced minute ventilation. Increasing the tidal volume from 6 to 12 ml/kg PBW was capable of attenuating the evolution of respiratory acidosis related to endotracheal tube occlusion occurring as a consequence of bronchoscopy. However, this effect was only evident when using larger endotracheal tube sizes of ≥8 mm ID.

Additional files
================

 {#Sec12}

Additional file 1:pH-value during dilatational tracheostomy. Tidal volume was set to 6 ml/kg PBW for the entire period. \**p* ≤ 0.05, \*\**p* ≤ 0.01 and \*\*\**p* ≤ 0.001. (ET - endotracheal tube, I.D. - internal diameter). (PDF 1669 kb) Additional file 2:Decrease of pH-value during dilatational tracheostomy. Arterial blood gas analysis was performed at the beginning and end of the procedure. Patients were ventilated with tidal volumes (V~t~) of 6 or 12 ml/kg PBW during intervention. \**p* ≤ 0.05 and \*\**p* ≤ 0.01. (ET - endotracheal tube, I.D. - internal diameter). (PDF 1075 kb) Additional file 3:Changes in PaCO~2~ during bronchoscopy-guided percutaneous dilatational tracheostomy: 6 versus 12 ml/kg PBW. (DOCX 16 kb) Additional file 4:Changes in pH during bronchoscopy-guided percutaneous dilatational tracheostomy: 6 versus 12 ml/kg PBW. (DOCX 16 kb)
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